Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 442

1.

Factors associated with perceived need for mental health care in multiple sclerosis.

Orr J, Bernstein CN, Graff LA, Patten SB, Bolton JM, Sareen J, Marriott JJ, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Mult Scler Relat Disord. 2018 Jul 29;25:179-185. doi: 10.1016/j.msard.2018.07.043. [Epub ahead of print]

2.

The effect of child hunger on educational attainment and early childbearing outcomes in a longitudinal population sample of Canadian youth.

McIntyre L, Kwok C, Patten SB.

Paediatr Child Health. 2018 Aug;23(5):e77-e84. doi: 10.1093/pch/pxx177. Epub 2017 Dec 22.

PMID:
30046272
3.

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study.

Vallerand IA, Lewinson RT, Frolkis AD, Lowerison MW, Kaplan GG, Swain MG, Bulloch AGM, Patten SB, Barnabe C.

RMD Open. 2018 Jul 11;4(2):e000670. doi: 10.1136/rmdopen-2018-000670. eCollection 2018.

4.

Safety of psychotropic medicines: looking beyond randomised evidence.

Barbui C, Patten SB.

Epidemiol Psychiatr Sci. 2018 Jul 13:1-2. doi: 10.1017/S2045796018000306. [Epub ahead of print] No abstract available.

PMID:
30001764
5.

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study.

Hirsch L, Patten SB, Bresee L, Jette N, Pringsheim T.

BJPsych Open. 2018 Jul;4(4):256-261. doi: 10.1192/bjo.2018.33.

6.

Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.

Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, Graff LA, Patten SB, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Inflamm Bowel Dis. 2018 Jul 7. doi: 10.1093/ibd/izy235. [Epub ahead of print]

PMID:
29986021
7.

Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.

Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Jul - Aug;53:65-72. doi: 10.1016/j.genhosppsych.2018.06.001. Epub 2018 Jun 7.

PMID:
29929117
8.

Social support and maternal mental health at 4 months and 1 year postpartum: analysis from the All Our Families cohort.

Hetherington E, McDonald S, Williamson T, Patten SB, Tough SC.

J Epidemiol Community Health. 2018 Jun 19. pii: jech-2017-210274. doi: 10.1136/jech-2017-210274. [Epub ahead of print]

PMID:
29921649
9.

Psoriasis and the risk of foot and ankle tendinopathy or enthesopathy in the absence of psoriatic arthritis: a population-based study.

Lewinson RT, Vallerand IA, Parsons LM, LaMothe JM, Frolkis AD, Lowerison MW, Kaplan GG, Patten SB, Barnabe C.

RMD Open. 2018 May 21;4(1):e000668. doi: 10.1136/rmdopen-2018-000668. eCollection 2018.

10.

Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.

McKay KA, Marrie RA, Fisk JD, Patten SB, Tremlett H.

Neuroepidemiology. 2018;51(1-2):1-10. doi: 10.1159/000488799. Epub 2018 May 15.

PMID:
29763935
11.

Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice.

Josephson CB, Engbers JDT, Jette N, Patten SB, Sajobi TT, Marshall D, Lowerison M, Wiebe S.

Epilepsy Behav. 2018 Jul;84:49-55. doi: 10.1016/j.yebeh.2018.04.012. Epub 2018 May 9.

PMID:
29753294
12.

Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews.

Levis B, Benedetti A, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Chiovitti MJ, Sanchez TA, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Steele RJ, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Beraldi A, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Chowdhary N, Clover K, Conwell Y, de Man-van Ginkel JM, Delgadillo J, Fann JR, Fischer FH, Fischler B, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Hambridge J, Harrison PA, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki M, Ismail K, Jetté N, Khamseh ME, Kiely KM, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, Marsh L, McGuire A, Mohd Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van der Feltz-Cornelis CM, van Weert HC, Vöhringer PA, White J, Whooley MA, Winkley K, Yamada M, Zhang Y, Thombs BD.

Br J Psychiatry. 2018 Jun;212(6):377-385. doi: 10.1192/bjp.2018.54. Epub 2018 May 2.

PMID:
29717691
13.

Effects of depression and anxiety on quality of life in five common neurological disorders.

Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N.

Gen Hosp Psychiatry. 2018 May - Jun;52:58-63. doi: 10.1016/j.genhosppsych.2018.03.009. Epub 2018 Apr 4.

PMID:
29684713
14.

Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis.

Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, Leung S, Fiest KM, McKay KA, Fisk JD; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Int J MS Care. 2018 Mar-Apr;20(2):76-84. doi: 10.7224/1537-2073.2016-110.

15.

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Inflamm Bowel Dis. 2018 Apr 13. doi: 10.1093/ibd/izy068. [Epub ahead of print]

PMID:
29668911
16.

Depressive Symptomatology, Syndromal Depression, and HIV-Associated Neurocognitive Disorder (HAND).

Goodkin K, Patten SB.

Can J Psychiatry. 2018 May;63(5):284-286. doi: 10.1177/0706743718754537. No abstract available.

PMID:
29668329
17.

Is depression screening in patients with acne critical?: reply from authors.

Vallerand IA, Lewinson RT, Parsons LM, Lowerison MW, Frolkis AD, Kaplan GG, Barnabe C, Bulloch AGM, Patten SB.

Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16673. [Epub ahead of print] No abstract available.

PMID:
29654704
18.

Validating screening tools for depression in Parkinson's disease.

Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, Gill S, Bulloch AGM, Hu B, Jette N.

Mov Disord. 2018 Mar 24. doi: 10.1002/mds.27371. [Epub ahead of print] No abstract available.

PMID:
29573354
19.

Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2018 Apr 10;90(15):e1316-e1323. doi: 10.1212/WNL.0000000000005302. Epub 2018 Mar 9.

PMID:
29523642
20.

Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.

Litster B, Bernstein CN, Graff LA, Walker JR, Fisk JD, Patten SB, Bolton JM, Sareen J, El-Gabalawy R, Marrie RA.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1641-1648. doi: 10.1093/ibd/izy032.

PMID:
29522100
21.

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.

Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):970-978. doi: 10.1002/acr.23539. Epub 2018 May 21.

22.

Risk of depression among patients with acne in the U.K.: a population-based cohort study.

Vallerand IA, Lewinson RT, Parsons LM, Lowerison MW, Frolkis AD, Kaplan GG, Barnabe C, Bulloch AGM, Patten SB.

Br J Dermatol. 2018 Mar;178(3):e194-e195. doi: 10.1111/bjd.16099. Epub 2018 Feb 7. No abstract available.

PMID:
29411352
23.

Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Mar - Apr;51:71-78. doi: 10.1016/j.genhosppsych.2018.01.003. Epub 2018 Jan 11.

PMID:
29353127
24.

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Marrie RA, Graff L, Walker JR, Fisk JD, Patten SB, Hitchon CA, Lix LM, Bolton J, Sareen J, Katz A, Berrigan LI, Marriott JJ, Singer A, El-Gabalawy R, Peschken CA, Zarychanski R, Bernstein CN.

JMIR Res Protoc. 2018 Jan 17;7(1):e15. doi: 10.2196/resprot.8794.

25.

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott JJ, Bernstein CN.

Mult Scler Relat Disord. 2018 Feb;20:9-15. doi: 10.1016/j.msard.2017.12.007. Epub 2017 Dec 16.

26.

Discriminative ability of quality of life measures in multiple sclerosis.

Fiest KM, Greenfield J, Metz LM, Patten SB, Jetté N, Marrie RA.

Health Qual Life Outcomes. 2017 Dec 21;15(1):246. doi: 10.1186/s12955-017-0828-0.

27.

Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care.

Turcotte LA, Marrie RA, Patten SB, Hirdes JP.

Can J Neurol Sci. 2018 Mar;45(2):188-198. doi: 10.1017/cjn.2017.274. Epub 2017 Dec 18.

PMID:
29251260
28.

Featured Canadian Research on Child, Adolescent, and Young Adult Psychiatry.

Patten SB.

Can J Psychiatry. 2017 Dec;62(12):810-812. doi: 10.1177/0706743717742864. No abstract available.

29.

Online tools for individuals with depression and neurologic conditions: A scoping review.

Lukmanji S, Pham T, Blaikie L, Clark C, Jetté N, Wiebe S, Bulloch A, Holroyd-Leduc J, Macrodimitris S, Mackie A, Patten SB.

Neurol Clin Pract. 2017 Aug;7(4):344-353. doi: 10.1212/CPJ.0000000000000365. Review.

30.

Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it.

Jetté N, Amoozegar F, Patten SB.

Neurol Clin Pract. 2017 Apr;7(2):118-127. doi: 10.1212/CPJ.0000000000000349. Review.

31.

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

BMC Res Notes. 2017 Nov 25;10(1):619. doi: 10.1186/s13104-017-2958-1.

32.

The prevalence of anxiety and associated factors in persons with multiple sclerosis.

Pham T, Jetté N, Bulloch AGM, Burton JM, Wiebe S, Patten SB.

Mult Scler Relat Disord. 2018 Jan;19:35-39. doi: 10.1016/j.msard.2017.11.003.

PMID:
29125968
33.

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.

Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Neurology. 2017 Dec 12;89(24):2455-2461. doi: 10.1212/WNL.0000000000004716. Epub 2017 Nov 8.

PMID:
29117961
34.

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Epidemiol Psychiatr Sci. 2017 Nov 3:1-10. doi: 10.1017/S2045796017000579. [Epub ahead of print]

PMID:
29098977
35.

Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship.

Vallerand IA, Patten SB.

Br J Dermatol. 2018 Jan;178(1):305. doi: 10.1111/bjd.16018. Epub 2018 Jan 10. No abstract available.

PMID:
28975606
38.
39.

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Causes of Death Collaborators.

Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9.

40.
41.

The prevalence of depression and the accuracy of depression screening tools in migraine patients.

Amoozegar F, Patten SB, Becker WJ, Bulloch AGM, Fiest KM, Davenport WJ, Carroll CR, Jette N.

Gen Hosp Psychiatry. 2017 Sep;48:25-31. doi: 10.1016/j.genhosppsych.2017.06.006. Epub 2017 Jun 15.

PMID:
28917391
42.

Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

J Psychosom Res. 2017 Oct;101:17-23. doi: 10.1016/j.jpsychores.2017.07.015. Epub 2017 Aug 1.

43.

Depression Screening and Health Outcomes in Children and Adolescents: A Systematic Review.

Roseman M, Saadat N, Riehm KE, Kloda LA, Boruff J, Ickowicz A, Baltzer F, Katz LY, Patten SB, Rousseau C, Thombs BD.

Can J Psychiatry. 2017 Dec;62(12):813-817. doi: 10.1177/0706743717727243. Epub 2017 Aug 29. Review.

44.

Major depression and secondhand smoke exposure.

Patten SB, Williams JVA, Lavorato DH, Woolf B, Wang JL, Bulloch AGM, Sajobi T.

J Affect Disord. 2018 Jan 1;225:260-264. doi: 10.1016/j.jad.2017.08.006. Epub 2017 Aug 12.

PMID:
28841490
45.

Hospital treatment costs and length of stay associated with hypertension and multimorbidity after hemorrhagic stroke.

Specogna AV, Turin TC, Patten SB, Hill MD.

BMC Neurol. 2017 Aug 10;17(1):158. doi: 10.1186/s12883-017-0930-2.

46.

Author response: Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Jette N, Fiest KM, Sauro KM, Wiebe S, Patten SB.

Neurology. 2017 Aug 8;89(6):641-642. doi: 10.1212/WNL.0000000000004206. No abstract available.

PMID:
28784639
47.

Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.

GBD 2015 Eastern Mediterranean Region Maternal Mortality Collaborators.

Int J Public Health. 2018 May;63(Suppl 1):47-61. doi: 10.1007/s00038-017-1004-3. Epub 2017 Aug 3.

48.

The burden of mental disorders in the Eastern Mediterranean region, 1990-2015: findings from the global burden of disease 2015 study.

GBD 2015 Eastern Mediterranean Region Mental Health Collaborators.

Int J Public Health. 2018 May;63(Suppl 1):25-37. doi: 10.1007/s00038-017-1006-1. Epub 2017 Aug 3.

49.

The depression and marital status relationship is modified by both age and gender.

Bulloch AGM, Williams JVA, Lavorato DH, Patten SB.

J Affect Disord. 2017 Dec 1;223:65-68. doi: 10.1016/j.jad.2017.06.007. Epub 2017 Jul 4.

PMID:
28732242
50.

Determinants and incidence of depression in multiple sclerosis: A prospective cohort study.

Berzins SA, Bulloch AG, Burton JM, Dobson KS, Fick GH, Patten SB.

J Psychosom Res. 2017 Aug;99:169-176. doi: 10.1016/j.jpsychores.2017.06.012. Epub 2017 Jun 15.

PMID:
28712424

Supplemental Content

Loading ...
Support Center